Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases(2023)
摘要
BACKGROUND:Respiratory syncytial virus (RSV) is widely known as a frequent cause of respiratory distress among adults, particularly in older people. Recent years have witnessed several improvements in respiratory virus detection, leading to more questions about therapeutic management strategies.
OBJECTIVES:This narrative review focuses on the RSV burden in older people and adults with risk factors and provides an update on the main recent developments regarding managing this infection.
SOURCES:A comprehensive PubMed search was conducted till August 2023 to identify studies on RSV among the adult population. We included observational studies, RCTs on vaccines, and different therapies.
CONTENT:This review should give clinicians an overview of RSV epidemiology and burden among older people and adults with pre-existing risk factors, the most recent randomized clinical trials on RSV vaccines, and the existing data on the different therapeutics existing and under development.
IMPLICATIONS:There is a growing body of evidence on RSV burden in adults. The landscape of preventive and curative treatments is quickly evolving.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要